As shown in Table 3, the optimal cut-off point for ALT, supported by Youden's Index for screening MetS , was 21.3 U/L in males, which showed a sensitivity of 72.1% and specificity of 47.1%. This evidence concerns the gene GPT and metabolic syndrome.